Our high glucose infusion rate was meant to overrule the controller in order to create hyperglycemia (> 10 mmol/L) and assess for the occurrence of “rebound” hypoglycemia secondary to the insulin doses used to treat the hyperglycemic excursion. This evidence concerns the gene INS and Hyperglycemia.